| Patents for A01K 67 - Rearing or breeding animals, not otherwise provided for; New breeds of animals (34,042) |
|---|
| 07/03/2001 | US6255556 Lean transgenic animals |
| 07/03/2001 | US6255555 Transgenic mouse expressing human fusin and human CD4 |
| 07/03/2001 | US6255554 Transgenic non-human mammals expressing human coagulation factor VIII and von Willebrand factor |
| 07/03/2001 | US6255473 Regulatory sequences coding heterologous protein; for use as tools in the diagnosis and treatment of alzheimer's disease |
| 07/03/2001 | US6255458 High affinity human antibodies and human antibodies against digoxin |
| 07/03/2001 | US6255113 Targeting an exogenous polynucleotide or complementary polynucleotide pair to an endogenous dna target in eukaryotic cells by homologous recombination; genetic disease therapy; sickle cell anemia, thalassemias and genetic cancers |
| 07/03/2001 | US6254867 Human monoclonal antibodies to the hepatitis B surface antigen |
| 07/03/2001 | US6254865 Method of treating huntington's disease using HNT neurons |
| 06/28/2001 | WO2001046699A1 INHIBITION OF βARRESTIN MEDIATED EFFECTS PROLONGS AND POTENTIATES OPIOID RECEPTOR-MEDIATED ANALGESIA |
| 06/28/2001 | WO2001046444A1 Double selection vector |
| 06/28/2001 | WO2001046406A2 New qtl's on chromosomes x, 2, 6 and 7 of pigs |
| 06/28/2001 | WO2001046258A2 Transporters and ion channels |
| 06/28/2001 | WO2001045751A1 Angiogenesis and vascular permeability modulators and inhibitors |
| 06/28/2001 | WO2001045500A1 A method to produce cloned embryos and adults from cultured cells |
| 06/28/2001 | WO2000074693A3 Immunity generation |
| 06/28/2001 | WO2000073344A3 Monoclonal antibodies, synthetic and biotechnological derivatives thereof acting as ngf-antagonist molecules |
| 06/28/2001 | WO2000070049A3 Extracellular signaling molecules |
| 06/28/2001 | WO1997046686A3 Tumor necrosis factor-related polypeptide |
| 06/28/2001 | CA2395136A1 Angiogenesis and vascular permeability modulators and inhibitors |
| 06/28/2001 | CA2395007A1 Transporters and ion channels |
| 06/28/2001 | CA2394812A1 A method to produce cloned embryos and adults from cultured cells |
| 06/28/2001 | CA2394743A1 Inhibition of .beta.arrestin mediated effects prolongs and potentiates opioid receptor-mediated analgesia |
| 06/28/2001 | CA2392827A1 Double selection vector |
| 06/27/2001 | EP1111061A1 Double selection vector |
| 06/27/2001 | EP1111048A2 Neutral amino acid transporter and gene thereof |
| 06/27/2001 | EP1111043A1 New QTL's on chromosomes X, 2, 6 and 7 of pigs |
| 06/27/2001 | EP1109907A1 Human cell junction pdz protein |
| 06/27/2001 | EP1109906A1 Methods and compositions for modulating the interaction between the apj receptor and the hiv virus |
| 06/27/2001 | EP1109891A1 Method for producing cloned cows |
| 06/27/2001 | EP1109890A1 Method for producing human cloned embryos by employing inter-species nuclear transplantation technique |
| 06/27/2001 | EP1109887A1 Production and use of dopaminergic cells to treat dopaminergic deficiencies |
| 06/27/2001 | EP1109822A1 Factor 8 homologue nucleic acids, polypeptides, methods, uses |
| 06/27/2001 | EP1109571A2 Methods of treating hypertension and compositions for use therein |
| 06/27/2001 | CN1301299A production of biofilaments in transgenic animals |
| 06/26/2001 | US6252136 Transgenic organisms having tetracycline-regulated transcriptional regulatory systems |
| 06/26/2001 | US6252133 Regenerating embryo of mammal; transfer nucleus of diploid cell into oocyte, activate and develop embryo |
| 06/26/2001 | US6252131 Transgenic mammal having 5-HT3 transgene overexpression in the CMS |
| 06/26/2001 | US6252130 Production of somatic mosaicism in mammals using a recombinatorial substrate |
| 06/26/2001 | US6251853 Pertussis toxin (ptx); beta-3 subunit of human g protein with not more than six wd repeat motifs; for the diagnosis of disorders, such as a disease associated with g protein dysregulation (i.e. hypertension) |
| 06/26/2001 | US6251640 Genetically engineered virus having tata element promoter, tet operator sequence, and a gene which inhibits replication of virus when expressed; gene therapy; vaccines; viricides |
| 06/26/2001 | US6251384 Metastasis models using green fluorescent protein (GFP) as a marker |
| 06/26/2001 | US6250306 Assessment of ischemic wound healing therapeutics |
| 06/21/2001 | WO2001044483A1 Transgenic insect |
| 06/21/2001 | WO2001044472A1 Tnfr/opg-like molecules and uses thereof |
| 06/21/2001 | WO2001044461A1 Hoxc13 transgenic mice exhibiting hair loss and ichthyosis-like syndrome |
| 06/21/2001 | WO2001044448A2 Human oxidoreductase proteins |
| 06/21/2001 | WO2001044295A2 Agonists and antagonists of the receptor gpr19 and their use in appetite control |
| 06/21/2001 | WO2001044282A2 Bcl-g polypeptides, encoding nucleic acids and methods of use |
| 06/21/2001 | WO2001043540A2 Methods for producing transgenic animals |
| 06/21/2001 | WO2001043539A1 Animals with insufficient expression of uridine phosphorylase |
| 06/21/2001 | WO2001018195A3 Luciferase expression cassettes and methods of use |
| 06/21/2001 | WO2001000795A9 A method for producing cloned cows |
| 06/21/2001 | WO2000075278B1 Gene encoding nade, p75ntr-associated cell death executor and uses thereof |
| 06/21/2001 | DE19956513A1 Resolvase-katalysierte, Sequenz-spezifische DNA-Rekombination in eukaryotischen Zellen Resolvase-catalyzed sequence-specific DNA recombination in eukaryotic cells |
| 06/21/2001 | CA2394600A1 Methods for producing transgenic animals |
| 06/21/2001 | CA2394536A1 Tnfr/opg-like molecules and uses thereof |
| 06/21/2001 | CA2394160A1 Human oxidoreductase proteins |
| 06/21/2001 | CA2390662A1 Bcl-g polypeptides, encoding nucleic acids and methods of use |
| 06/20/2001 | EP1108059A2 Nucleic acids encoding human tbc-1 protein and polymorphic markers thereof |
| 06/20/2001 | EP1108058A1 Evolution of whole cells and organisms by recursive sequence recombination |
| 06/20/2001 | EP1108052A1 Method for remodelling an animal genome by zygotic transfer of a site-specific recombinase |
| 06/20/2001 | EP1108039A2 Elongase genes and uses thereof |
| 06/20/2001 | EP1108026A1 Nucleic acids encoding ataxin-2 binding proteins, products related thereto and methods of using same |
| 06/20/2001 | EP1108025A2 Phelix: a testis-specific protein expressed in cancer |
| 06/20/2001 | EP1108021A2 Human genes differentially expressed in colorectal cancer |
| 06/20/2001 | EP1108008A1 Novel ubiquitin ligases as therapeutic targets |
| 06/20/2001 | EP1107796A2 Cells expressing immunoregulatory molecules and uses therefor |
| 06/20/2001 | EP0842188A4 Mutant s182 genes |
| 06/20/2001 | CN1067211C Commercial cultivating method and equipment for fly maggot |
| 06/19/2001 | US6248933 Cellular basis of vascular-graft stenosis |
| 06/19/2001 | US6248721 Method of using mouse model for evaluation of HIV vaccines |
| 06/19/2001 | US6248517 Amino acid sequences; diagnosis of lyme disease; recombinant production; vaccines |
| 06/14/2001 | WO2001042789A1 MARKERS FOR IDENTIFICATION AND ISOLATION OF PANCREATIC ISLET α AND β CELL PROGENITORS |
| 06/14/2001 | WO2001042465A2 Chordin-like molecules and uses thereof |
| 06/14/2001 | WO2001042451A2 FULL-LENGTH HUMAN cDNAs ENCODING POTENTIALLY SECRETED PROTEINS |
| 06/14/2001 | WO2001042444A2 Methods for expression of genes in primates |
| 06/14/2001 | WO2001042421A2 Long-term cell culture compositions and genetically modified animals derived therefrom |
| 06/14/2001 | WO2001042305A1 Interleukin-1 receptor antagonist-like molecules and uses thereof |
| 06/14/2001 | WO2001042301A1 Interferon-alpha induced gene |
| 06/14/2001 | WO2001042290A2 Novel steroid-activated nuclear receptors and uses therefor |
| 06/14/2001 | WO2001042288A2 G-protein coupled receptors |
| 06/14/2001 | WO2001042283A2 Sex-chromosome-specific proteins, species specific and sperm specific proteins and methods for their identification and isolation |
| 06/14/2001 | WO2001041792A1 Interleukin-1 receptor antagonist-like molecules and uses thereof |
| 06/14/2001 | CA2394970A1 Novel steroid-activated nuclear receptors and uses therefor |
| 06/14/2001 | CA2394303A1 Interferon-alpha induced gene |
| 06/14/2001 | CA2393661A1 Interleukin-1 receptor antagonist-like molecules and uses thereof |
| 06/14/2001 | CA2393532A1 Interleukin-1 receptor antagonist-like molecules and uses thereof |
| 06/14/2001 | CA2393433A1 Sex-chromosome-specific proteins, species specific and sperm specific proteins and methods for their identification and isolation |
| 06/14/2001 | CA2393071A1 Long-term cell culture compositions and genetically modified animals derived therefrom |
| 06/14/2001 | CA2392961A1 G-protein coupled receptors |
| 06/14/2001 | CA2392299A1 Methods for expression of genes in primates |
| 06/14/2001 | CA2382165A1 Full-length human cdnas encoding potentially secreted proteins |
| 06/13/2001 | EP1106689A2 Nucleic acids encoding acetylcholine beta subunits from insects |
| 06/13/2001 | EP1106061A1 Method for modifying chromosomes |
| 06/13/2001 | EP1106060A1 Model animal with visualized nerve network |
| 06/13/2001 | EP1105734A2 Homer interacting proteins |
| 06/13/2001 | EP1105538A2 HUMAN STEAROYL-CoA DESATURASE-RELATED COMPOSITIONS AND METHODS FOR TREATING SKIN DISORDERS |
| 06/13/2001 | EP1105479A2 Identification of the gene causing the mouse scurfy phenotype and its human ortholog |
| 06/13/2001 | EP1105469A1 Mammalian transgenesis by intracytoplasmic sperm injection |
| 06/13/2001 | EP1105459A1 Transgenic nonhuman mammal and uses thereof to identify compounds useful for improving long-term memory |